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Abstract
Background:  Swimming behaviors in the forced swimming test have been reported to be
depressed by stressors. Since toxic convulsion-inducing drugs related to dopamine [cocaine
(COC)], benzodiazepine [methyl 6,7-dimethoxy-4-ethyl-β-carboline-carboxylate (DMCM)], γ-
aminobutyric acid (GABA) [bicuculline (BIC)], and glutamate [N-methyl-D-aspartate (NMDA)]
receptors can function as stressors, the present study compared their effects on the forced
swimming behaviors with the effects of immobilization stress (IM) in rats. Their interactions with
ethanol (EtOH), the most frequently coabused drug with COC which also induces convulsions as
withdrawal symptoms but interferes with the convulsions caused by other drugs, were also
investigated.
Results: Similar to the IM (10 min) group, depressed swimming behaviors (attenuated time until
immobility and activity counts) were observed in the BIC (5 mg/kg IP) and DMCM (10 mg/kg IP)
groups at the 5 h time point, after which no toxic behavioral symptoms were observed. However,
they were normalized to the control levels at the 12 h point, with or without EtOH (1.5 g/kg IP).
In the COC (60 mg/kg IP) and NMDA (200 mg/kg IP) groups, the depression occurred late (12 h
point), and was normalized by the EtOH cotreatment. At the 5 h point, the COC treatment
enhanced the swimming behaviors above the control level.
Conclusions:  Although the physiological stress (IM), BIC, and DMCM also depressed the
swimming behaviors, a delayed occurrence and EtOH-induced recovery of depressed swimming
were observed only in the COC and NMDA groups. This might be correlated with the previously-
reported delayed responses of DA and NMDA neurons rather than direct effects of the drugs,
which could be suppressed by EtOH. Furthermore, the characteristic psychostimulant effects of
COC seemed to be correlated with an early enhancement of swimming behaviors.
Background
Similarities between the effects of several convulsants and
physiological stressors have been suggested, based on the
close relationship between stressors and seizure-related
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brain receptors such as γ-aminobutyric acid (GABA) (in-
cluding benzodiazepine binding sites), and N-methyl-D-
aspartate (NMDA) glutamate receptors [1–3]. Cocaine
(COC), a dopaminergic psychostimulant, has also been
reported to be one of the "stressor-like" convulsion-induc-
ing drugs, because physiological stressors such as a foot
shock induced a dopamine (DA) transporter blockade
similar to COC [4,5]. Furthermore, COC can be differen-
tiated from other convulsants and stressors, because it is a
drug of abuse, and the euphoric enhancement of locomo-
tor activities can be observed even at toxic doses [6]. How-
ever, it is also possible that GABA receptor antagonists
such as bicuculline (BIC), benzodiazepine receptor in-
verse agonists such as methyl 6,7-dimethoxy-4-ethyl-β-
carboline-carboxylate (DMCM), and glutamate receptor
agonists such as NMDA also function as stressors, because
of their convulsion-inducing effects and the close correla-
tion between their target receptors and the stress response
[1–3]. Although these drugs, including COC, have differ-
ent target receptors, previous studies on the convulsive
profiles of each drug have reported no peculiar differences
with respect to the induction of stress reactions [7].
It can be predicted that various anticonvulsant drugs func-
tion as therapeutic antagonists against convulsants, and
attenuate both the toxic and the above stressor-like effects
produced by convulsion-inducing drugs, including COC.
However, among the convulsion-relieving drugs, ethanol
(EtOH) is characterized by its own acute and chronic de-
pressive toxicity [8]. Furthermore, EtOH can cause both
stressor-like effects and convulsions as withdrawal symp-
toms by itself, and can enhance some of the effects of con-
vulsant drugs [9–13]. In previous studies, however, low
doses of EtOH attenuated the effects of stressors [14]. In
particular, EtOH enhanced COC-induced euphoric effects
and attenuated subjective pain, and is actually the most
frequently coabused drug with COC [15,16]. Further-
more, there are reports that suggest that the anticonvul-
sant effects of EtOH against convulsant drugs may be
related to both GABA (including benzodiazepine) and
NMDA receptors [17–19]. Thus, it is possible that some of
the stressor-like effects caused by these convulsant drugs
could also be attenuated by EtOH.
In the present study, as one of the behavioral methods re-
ported for evaluating the strength of stressor effects, the
forced swimming test [20–22] was performed in groups of
rats treated with a toxic, convulsant dose of COC and oth-
er convulsion-inducing drugs, after when no toxic behav-
ioral symptoms including convulsions were observed. The
swimming behaviors in these drug-treatment groups were
then compared with groups of rats treated with a physio-
logical stressor in order to detect any modifications of the
swimming behaviors peculiar to the groups treated with
the convulsion-inducing drugs, and which could not be
induced by a physiological stressor (IM). Furthermore,
based on the above-mentioned anticonvulsant-like effects
of EtOH, modifications in the swimming behaviors
caused by a non-toxic dose of EtOH were also examined,
with special attention to the possible stress-relieving ef-
fects of EtOH against both physiological stress and con-
vulsion-inducing drugs.
Results
Lethality and convulsive seizures caused by convulsion-in-
ducing drugs before forced swimming (Table 1)
In the drug-treatment groups, the mortality rate, the sever-
ity of the convulsive seizures [percentage, score of the
most frequent type of seizure (score of the most frequent
seizure), score of the most severe type of seizure (score of
the most severe seizure), and time to recovery from visible
seizures in the surviving rats (time to recovery)], and the
total number of rats examined are shown in Table 1. A to-
tal of five surviving rats from each group were subjected to
an examination by the forced swimming test. Even with
ethanol and other treatments, the values for the body
weights were not significantly altered. Furthermore, no
difference was observed in the weight between the surviv-
ing and dead animals. In the EtOH-cotreatment groups,
the values for the parameters of the convulsive seizures
were significantly (p < 0.01; two sample t test with Welch's
correction) attenuated as compared to the corresponding
non-EtOH groups [t = 4.75 with df (degree of freedom) =
13 (score of the most frequent seizures), t = 6.38 with df =
15 (score of the most severe seizures) and t = 3.45 with df
= 8 (time to recovery) in the COC-EtOH vs. COC groups,
t = 3.64 with df = 12 (score of the most frequent seizures),
t = 4.35 with df = 13 (score of the most severe seizures)
and t = 4.06 with df = 7 (time to recovery) in the BIC-
EtOH vs. BIC groups, t = 3.11 with df = 12 (score of the
most frequent seizures), t = 3.71 with df = 13 (score of the
severe seizures) and t = 4.93 with df = 8 (time to recovery)
in the DMCM-EtOH vs. DMCM groups, and t = 4.16 with
df = 13 (score of the most frequent seizures), t = 5.13 with
df = 13 (score of the most severe seizures) and t = 4.72
with df = 7 (time to recovery) in the NMDA-EtOH vs.
NMDA groups]. However, within the non-EtOH groups
(between the COCA, BIC, DMCM and NMDA groups)
and within the EtOH-cotreatment groups (between the
COCA-EtOH, BIC-EtOH, DMCM-EtOH and NMDA-
EtOH groups), no significant difference [p > 0.05; one-
way analysis of varience (ANOVA)] was observed for ei-
ther the seizure scores or the time to recovery [F(3, 36) =
0.13 (score of the most frequent seizures), F(3, 36) = 0.18
(score of the most severe seizures) and F(3, 16) = 0.23
(time to recovery) within the non-EtOH groups, and F(3,
36) = 0.13 (score of the most frequent seizures), F(3, 36)
= 0.14 (score of the most severe seizures) and F(3, 16) =
0.52 (time to recovery) within the EtOH-cotreatment
groups].BMC Pharmacology 2002, 2 http://www.biomedcentral.com/1471-2210/2/19
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Forced swimming test (Fig 1)
At 5 h after the treatment, both indices of swimming be-
haviors [time to immobility (time) and activity counts
(counts), as explained in the Methods section] were signif-
icantly (p < 0.05; two sample t test with Welch's correc-
tion) attenuated in the BIC, DMCM, and IM groups as
compared to the control group [t = 4.19 with df = 6 (time)
and t = 2.35 with df = 8 (counts) in the BIC group, t = 4.19
with df = 6 (time) and t = 2.51 with df = 8 (counts) in the
DMCM group, t = 3.25 with df = 7 (time) and t = 3.05 with
df = 7 (counts) in the IM group]. However, in the COC
group at this time point, both the time to immobility (t =
1.63 with df = 8, P = 0.14) and the activity counts (t = 2.66
with df = 8, p < 0.05) tended to be increased above con-
trol, suggesting enhanced swimming behaviors. At 12 h,
the attenuated swimming behaviors in the BIC, DMCM,
and IM groups returned to normal levels, which were not
significantly different from the control (p > 0.05; two
sample t test with Welch's correction). On the other hand,
at the 12 h time point, a significant attenuation of the
swimming behaviors as compared to the control group (p
< 0.05; two sample t test with Welch's correction) was also
observed in the COC and NMDA groups [t = 3.35 with df
= 8 (time) and t = 2.33 with df = 8 (counts) in the COC
group, t = 4.42 with df = 7 (time) and t = 2.87 with df = 7
(counts) in the NMDA group]. Nevertheless, none of the
values differed significantly (p > 0.05; one-way ANOVA)
from the control values at the 24 h time point [F(5, 24) =
0.08 (time), F(5, 24) = 0.05 (counts)].
In all groups, EtOH (1.5 g/kg) did not alter the suppres-
sion of the swimming behaviors as compared to the con-
trols. Furthermore, in the EtOH-only group (control
group with EtOH treatment), no significant modifications
in the swimming behaviors were observed as compared to
the control group without EtOH treatment, at any time
point. At 5 h, the swimming behaviors were significantly
attenuated (p < 0.05 for both time to immobility and ac-
tivity counts; two sample t test with Welch's correction) in
the BIC-EtOH, DMCM-EtOH, and IM-EtOH groups as
compared to the control group with or without EtOH
treatment [vs. control group without EtOH treatment: t =
3.59 with df = 7 (time) and t = 2.20 with df = 8 (counts)
in the BIC-EtOH group, t = 3.59 with df = 7 (time) and t =
2.18 with df = 8 (counts) in the DMCM-EtOH group, and
t = 3.06 with df = 8 (time) and t = 2.45 with df = 8 (counts)
in the IM-EtOH group; vs. control group with EtOH treat-
ment, t = 3.59 with df = 7 (time) and t = 2.08 with df = 8
(counts) in the BIC-EtOH group, t = 3.59 with df = 7
(time) and t = 2.04 with df = 8 (counts) in the DMCM-
EtOH group, t = 3.06 with df = 8 (time) and t = 2.31 with
df = 8 (counts) in the IM-EtOH group]. Furthermore, the
values for the swimming behaviors were not significantly
altered as compared to the corresponding non-EtOH
Table 1: Mortality rate (%), and the percentage and severity of the convulsive seizures in the CV groups.
Treatment Mortality Rate (%) Presence of 
Convulsive 
Seizures (%)
Score of the 
most frequent 
seizure
Score of the most 
severe seizure
Time to recovery 
(min)
COCA 60 mg/kg (n = 10) 50.0 90.0 2.3 ± 0.9 2.4 ± 0.7 192 ± 30
BIC 5 mg/kg (n = 10) 50.0 80.0 2.1 ± 1.1 2.3 ± 1.0 205 ± 35
DMCM 10 mg/kg (n = 10) 50.0 80.0 2.0 ± 1.2 2.1 ± 1.0 198 ± 28
NMDA 200 mg/kg (n = 10) 50.0 80.0 2.2 ± 1.0 2.3 ± 0.8 209 ± 36
COCA 60 mg/kg + EtOH 1.5 g/kg (n = 11) 54.5 63.6 0.7 ± 0.4 a 0.7 ± 0.4 a 124 ± 26 a
BIC 5 mg/kg + EtOH 1.5 g/kg (n = 10) 50.0 60.0 0.6 ± 0.5 a 0.7 ± 0.5 a 118 ± 24 a
DMCM 10 mg/kg + EtOH 1.5 g/kg (n = 9) 44.4 66.7 0.7 ± 0.5 a 0.7 ± 0.5 a 106 ± 24 a
NMDA 200 mg/kg + EtOH 1.5 g/kg (n = 10) 50.0 70.0 0.7 ± 0.5 a 0.8 ± 0.5 a 106 ± 25 a
Both the most severe convulsive seizure and the most frequent type of seizure observed in each rat were scored, based on previously-reported 
evaluation methods using the common features of convulsive seizures [47,48]: score 0=no convulsive seizures, score 1=short-lasting (< 5 min) mild 
episodes of clonic convulsions, score 2=short-lasting episodes of clonic-tonic convulsions that caused a loss of the righting reflex, and score 3= epi-
sodic convulsive seizures continuous and violent enough to cause fatal respiratory disorders. Furthermore, the mean time to recovery from visible 
seizures in the surviving rats, after when no seizures were observed, is also shown, although all of the convulsive seizures and other toxic symptoms 
(e.g. abnormal locomotor activities) had disappeared before the 5 h time point. The data for the seizure scores represent means ± SD. a: significant 
(p < 0.05; two sample t test with Welch's correction) attenuation as compared to the non-EtOH groups. In the groups without EtOH cotreatment 
(between the COCA, BIC, DMCM and NMDA groups), and within the groups with EtOH cotreatment (between the COCA-EtOH, BIC-EtOH, 
DMCM-EtOH and NMDA-EtOH groups), no significant differences were observed (p > 0.05; one-way ANOVA) for the scores of the most severe 
convulsive seizure, the scores of the most frequent type of seizure, and the time to recovery in the surviving rats. Furthermore, each mean value for 
the most frequent type of seizure was not significantly different from the mean value for the most severe type of seizures (p > 0.05; two sample t 
test with Welch's correction). In all rats, there was no significant difference between the most severe score and the most frequent score (p > 0.05; 
two sample t test with Welch's correction), which suggests a similar severity profile within the non-EtOH groups, and within the EtOH-cotreat-
ment groups.BMC Pharmacology 2002, 2 http://www.biomedcentral.com/1471-2210/2/19
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Figure 1
Time course of the forced swimming behaviors (time to immobility and activity counts), which were meas-
ured at the 5, 12 and 24 h time points after treatment. The data represent means ± SD (n = 5 for each group). A: sig-
nificant (p < 0.05; two sample t test with Welch's correction) increase as compared to the non-EtOH group; B, b: significant (p
< 0.05; two sample t test with Welch's correction) increase (B) or attenuation (b) as compared to the control group. In the
EtOH-cotreated groups, "B" and "b" denote significant alterations as compared to the control groups with and without EtOH
treatment.
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groups, and had returned to the levels for the control
group (with and without EtOH coadministration) at 12 h
(p > 0.05 for both time to immobility and activity counts;
two sample t test with Welch's correction). In the COC-
EtOH group, the swimming behaviors were significantly
increased above control levels at 5 h [vs. control group
without EtOH treatment: t = 2.53 with df = 8 (time) and t
= 2.72 with df = 8 (counts); vs. control group with EtOH
treatment, t = 2.53 with df = 8 (time) and t = 2.56 with df
= 8 (counts)], but returned to the levels for the control
group (with and without EtOH coadministration) at 12 h
(p > 0.05 for both time to immobility and activity counts;
two sample t test with Welch's correction). At 12 h, the
swimming behaviors were significantly increased (p <
0.01 for both time to immobility and activity counts; two
sample t test with Welch's correction) as compared to the
COC-only group [t = 3.81 with df = 8 (time) and t = 3.04
with df = 7 (counts)]. In the NMDA-EtOH group, none of
the indices of swimming behaviors were significantly al-
tered as compared to the control group (with and without
EtOH coadministration) at any time point (p > 0.05 for
both time to immobility and activity counts; two sample
t test with Welch's correction), and the swimming behav-
iors at 12 h were significantly increased (p < 0.01 for both
time to immobility and activity counts; two sample t test
with Welch's correction) as compared to the NMDA-only
group [t = 3.15 with df = 7 (time) and t = 2.96 with df = 8
(counts)]. Therefore, none of the values differed signifi-
cantly (p > 0.05; one-way ANOVA) from the control val-
ues at the 12 h time point [F(6, 28) = 0.54 (time), F(6, 28)
= 0.52 (counts)].
Throughout the experiments, a linear correlation was ob-
served between the time to immobility (X) and the activity
counts (Y), using simple regression analysis. All of the val-
ues could be approximated to the following equation: Y =
715.66X + 43.53 with F(1, 178) = 12.09 and p < 0.01.
Therefore, in all treatment groups in which the swimming
behaviors were suppressed, the time to immobility was
also attenuated in proportion to the activity counts. In our
observations, neither brief but violent swimming bursts
nor prolonged slow swimming were observed.
Discussion
The present results revealed that the depressive effects re-
ported for a physiological stressor (IM) [21,22] in the
forced swimming test were also mimicked by toxic doses
of convulsion-inducing drugs. However, the time course
of the indices of swimming behaviors (time until immo-
bility and activity counts) was different between each drug
treatment group, although the doses used caused convul-
sive seizures of similar severity and duration (Table 1).
The time course of the indices of swimming behaviors in
the IM group was similar to the BIC and DMCM groups
(Fig 1), and this is consistent with previous studies dem-
onstrating the contribution of brain GABA and benzodi-
azepine receptors to stress-related behavioral alterations
[1,3]. However, although very close relationships between
stress and NMDA receptors [2] and DA transporters [5]
have been reported, the depression of the swimming be-
haviors occurred at a later time point (12 h) in the COC
and NMDA groups. The detailed mechanisms responsible
for these delayed depressive effects have not been eluci-
dated, but there are reports demonstrating delayed afteref-
fects of COC and NMDA at toxic doses which seemed to
occur independently from the pharmacokinetics of the
drugs, even after when the drugs were eliminated [23,24].
Although the values of the half-lives of NMDA, BIC and
DMCM have not been elucidated, a previous study on the
drug distribution suggests an earlier elimination of COC
with a short half-life (about 30 min in rats) by hydrolysis
to the inactive metabolites [25], in spite of the convulsive
seizures at a similar severity to the other drug-treatment
groups (Table 1) and the characteristic delayed stress-like
responses in the forced swimming test (Fig 1). The de-
layed responses of brain DA transporters and NMDA re-
ceptors against stressors, including COC and NMDA, have
been reported in the previous studies, and have been sug-
gested to be correlated with prolonged excitation at the
neuronal level, which has been characteristically observed
for DA transporters and NMDA receptors after treatment
with strong DA- or glutamate-neuron-selective drugs or
stressors [23,24]. Furthermore, it is also possible that
these responses were induced by mediators other than the
drugs themselves. Since neuroendocrinal responses have
been reported to be correlated with various stress respons-
es [26–28], hormones such as those in the hypothalamic-
pituitary axis [26,27] could be regarded as some of the
proposed mediators. Although the coincidence with the
delayed behavioral alterations peculiar to the COC- or
NMDA-treated groups was not observed for representative
hormones such as ACTH and corticosterone (the peak lev-
els were observed earlier) in our previous study [29], it is
still possible that some of the related neuroendocrinal sys-
tems contributed to the prolonged neuronal excitation
and thus the delayed stress reaction on the swimming be-
haviors that was not induced by a physiological stressor
such as IM. Furthermore, the stress responses related to
some of the neuroendocrinal mediators could induce un-
favorable effects on the body [30,31].
In the COC group, an early (5 h) enhancement of the
swimming behaviors was characteristically observed, al-
though the convulsive seizures, hyperactivity and other
toxic alterations in locomotor activity known for high
doses of COC [32] had disappeared by that time point.
Unlike the other convulsion-inducing drugs, COC is
known to be the drug of abuse, and has been reported to
cause prolonged potentiation in DA neurons with a single
treatment, even after the drug had been eliminated fromBMC Pharmacology 2002, 2 http://www.biomedcentral.com/1471-2210/2/19
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the body, and to enhance locomotor activities by reward-
ed stimulations or other motivations [33–35]. Therefore,
it is possible in our experiment that the forced swimming
behavior, which may save the life of the rat after putting it
into the water, could function as such a driving motiva-
tion and thus enhance the swimming behaviors. Further-
more, our results showed that the psychostimulated
conditions, as demonstrated by the alterations in the
forced swimming behaviors, lasted for less than 12 hours,
because no enhancement in the swimming behaviors was
observed after the 12 h time point.
In spite of its equivalent convulsion-relieving effects (Ta-
ble 1), the effects of EtOH on the depressed swimming be-
haviors were different. Although the present non-toxic
dose of EtOH (1.5 g/kg IP) did not cause any further de-
pressive modifications on the forced swimming behaviors
(Fig 1), the BIC-, DMCM- and IM-attenuated swimming
behaviors at the earlier (5 h) time point were not signifi-
cantly modified by 1.5 g/kg EtOH. In contrast, the COC-
and NMDA-attenuated swimming behaviors at the later
(12 h) time point were significantly ameliorated as com-
pared to the COC- or NMDA-only groups (Fig 1). These
limited effects of EtOH in the COC- and NMDA-treated
groups have not been sufficiently investigated. However,
there are reports that suggest the presence of peculiar an-
tagonistic effects of EtOH on DA and glutamate neurons
[36,37], and thus there is a possibility that the delayed
stressor-like effects caused by the agonistic ligands COC
and NMDA were attenuated by EtOH. Furthermore, the
appearance of euphoric effects, which could possibly be
effective in attenuating the stressor effects, has been re-
ported for EtOH treatments combined with some DA and
NMDA receptor ligands [6,16,38]. In particular, with re-
spect to combined COC-EtOH treatments, the euphoric
effects of COC [34] have been reported to be enhanced by
EtOH, possibly due to DA receptor-mediated endocrinal
changes, the synthesis of the euphoric metabolite cocaeth-
ylene, etc [34,39]. On the other hand, NMDA alone has
not been reported to cause any euphoric effects. However,
a close correlation between EtOH-induced euphoric ef-
fects and NMDA receptors has been demonstrated by the
effects of some NMDA receptor ligands, which modified
the self-administration of EtOH [38]. The recovery from
the NMDA-attenuated swimming behaviors in the present
experiment might be correlated with these modified
EtOH effects. However, the "favorable effects" of EtOH
seem to be limited, considering that other studies have re-
ported more severe toxic effects of cocaethylene as com-
pared to COC [40], and enhanced toxicity of NMDA
caused by chronic EtOH cotreatment [41].
Conclusions
The present results suggest that toxic doses of convulsion-
inducing drugs caused depressive effects (attenuation of
the time to immobility and activity counts) similar to a
physiological stressor on the forced swimming behaviors
in rats. However, depending on the target receptors, the ef-
fects of the drugs were different. The DA receptor-related
drug COC and the glutamate receptor-related drug NMDA
also attenuated the time until immobility and activity
counts in the swimming behaviors, but the appearance of
these stressor effects was delayed as compared to the other
receptor related convulsive drugs and IM, which was con-
sistent with a delayed response of the target receptors. Fur-
thermore, the psychostimulant COC characteristically
increased the swimming behaviors at an earlier time
point, even when no spontaneous behavioral changes
were observed in the cage. Following cotreatment with a
non-toxic, convulsion-relieving dose of EtOH, the de-
pressed swimming behaviors recovered only in the COC
and NMDA groups. This may be due to the characteristic
interference of EtOH at DA transporters and NMDA recep-
tors, or the appearance of euphoric effects to relieve the
stressor effects in the limited conditions for COC-EtOH
and NMDA-EtOH combinations.
Methods
Animals and drug (immobilization stress) treatments
Adult male Wistar rats (280 ± 30 g) were purchased from
the Shizuoka Laboratory Animal Center (Hamamatsu, Ja-
pan). They were housed under conditions similar to a pre-
vious report [42], with a 12 h/12 h light/dark cycle. The
rats were kept in groups of 4 animals per cage (35 × 32 ×
16 cm) with woodchip bedding, and were allowed water
and lab chow ad libitum. The mean body weights in each
group did not differ significantly (ANOVA). The experi-
ments described in this report were conducted in accord-
ance with the "Guidelines for Animal Experiments" of our
institution (1988), which are based on the Guide for the
Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH publication No. 85-23,
revised 1985). Following these guidelines, if any severe
symptoms of pain induced by high doses of the drugs
were observed, the experiment was stopped.
The doses of COC and the other convulsion-inducing
drugs were selected based on previous studies [43–46].
The final doses used caused convulsive seizures of a simi-
lar severity (based on the criteria by De Sarro [47] and Bra-
ida [48]) and death in a similar percentage of rats, under
the present conditions, in a preliminary trial: 60 mg/kg for
COC hydrochloride (Takeda Chemical Industries, Ltd.,
Osaka Japan), 5 mg/kg for BIC (Tocris Cookson Inc., Ball-
win, MO, USA), 10 mg/kg for DMCM (Sigma-Aldrich,
Inc., Saint Louis, MO, USA), and 200 mg/kg for NMDA
(Nacalai Tesque, Inc., Kyoto, Japan). All of the convul-
sion-inducing drugs were administered by an intraperito-
neal (IP) injection of a mixed dimethylsulfoxide
(DMSO)-distilled water (1:2) solution in a volume of 5BMC Pharmacology 2002, 2 http://www.biomedcentral.com/1471-2210/2/19
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ml/kg body weight [7]. The group of rats treated with a
physiological stressor underwent 10 min of immobiliza-
tion stress [26], which was induced by placing the rat in a
narrow space (diameter 18 cm) made in a vinyl bag with
some breathing holes (IM group). In the EtOH-cotreated
groups of rats, 1.5 g/kg EtOH solution (IP), which has
been reported to cause euphoric effects but no fatal toxic-
ity [8], was injected 15 min before the convulsion-induc-
ing drugs or immobilization in a volume of 5 ml/kg. In
the EtOH-only group, the EtOH solution was injected 15
min before a vehicle control solution, a mixture of DMSO
and distilled water (1:2). In the control group, the same
vehicle solution was administered instead of the drugs.
In the drug-treated groups, the mortality rate and the se-
verity of the convulsive seizures [47,48] before each exam-
ination were also monitored and checked, using a video
camera (SONY CCD-TRV90).
Forced swimming test
For the purposes of evaluating the strength of the stressor-
like effects of each treatment, the forced swimming test
was performed at 5, 12, and 24 h after the treatments,
when all obvious drug-induced toxic behavioral symp-
toms had disappeared, in accordance with previous re-
ports [20–22]. The phenomenon of immobility in water,
which has been observed even under non-treatment con-
ditions and has been reported to be accelerated by the
loading of any stressor [21,22], was then compared with
the non-treated, control group of rats (n = 5). The appara-
tus consisted of a plastic cylinder 40 cm in height and 35
cm in diameter containing 25 cm of water at 21–23°C.
Quantitative alterations in the swimming behaviors were
then evaluated by: 1) the time to immobility, and 2) the
activity counts. The time until immobility was defined to
be the time after when only modest swimming move-
ments necessary to avoid drowning were observed. The ac-
tivity counts were recorded for 10 min, based on our
preliminary observations that the time to immobility did
not exceed 10 min in any group. The activity was counted
using the counting instrument Supermex (Muromachi
Kikai Co. Ltd., Tokyo, Japan) connected to the behavior
analyzing system CompACT AMS (Muromachi Kikai Co.
Ltd.) [49,50]. The sensor of the Supermex instrument was
positioned directly over the cylinder at a distance of 20 cm
from the water. This instrument can monitor swimming
movements in all three planes of motion (sagittal, coronal
and horizontal) as an infrared signal value using an infra-
red sensor with multiple Fresnel lenses, and then can eval-
uate the vigor of the swimming behaviors in addition to
the swimming distance evenly as sets of activity counts.
Therefore, by the combined evaluation of the activity
counts using the present method plus the time to immo-
bility, the overall magnitude of the swimming behaviors
could be analyzed.
The time interval between the drug administration and
each examination was consistent with the recovery time
from the severe toxic symptoms which interfered with the
swimming behaviors in our preliminary experiments (da-
ta not shown). During the earlier period (within 5 h after
the drug administration), toxic symptoms such as convul-
sive seizures and unusual activity, which seemed to mod-
ify the swimming behaviors and exposed the rats to the
danger of drowning, were observed. The interval between
the repeated tests (5, 12 and 24 h time points) in the sur-
vivors was determined based on data from the non-treat-
ment, control group which showed an absence of any
significant alterations in the two parameters of the swim-
ming behaviors (Fig 1).
Statistical analysis
For each treated and non-treated control group, the two
above-defined indices for the forced swimming test, and
the scores of the convulsive seizures were compared in or-
der to evaluate the effects of each stressor with or without
EtOH. A two sample t test with Welch's correction was
performed after the data were subjected to a one-way anal-
ysis of variance (ANOVA) repeatedly at each time point
[51]. For the comparison between the percentage of le-
thality and the convulsive seizures, Fisher's exact test was
used [51]. For the examination of the relationship be-
tween the parameters for the swimming behaviors, a sim-
ple regression analysis was used. All of the comparisons
were performed using statistical software packages and
their manuals (OMS Publication, Saitama, Japan). Unless
otherwise noted, p-values less than 0.05 were concluded
to be statistically significant.
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